Literature DB >> 10527886

Structural features and expression of an alternatively spliced growth factor type I receptor for follitropin signaling in the developing ovary.

P S Babu1, L Jiang, A M Sairam, R M Touyz, M R Sairam.   

Abstract

The pleiotropic actions of pituitary follitropin (FSH), regulate the expression of many cell cycle genes controlling ovarian follicular development and differentiation. In this study we asked the question whether different receptor motifs are created by the alternative splicing of the single large 80-100 Kb receptor gene. A 1.2 Kb transcript identified from a cDNA library of hormone primed (immature) sheep ovaries, codes for a putative protein lacking the seven transmembrane segment. The receptor of 259 amino acids designated FSH-R3 is derived from a transcript comprising the first eight exons of the Gs coupled larger FSH receptor (R1) spliced to another DNA segment. This event produces a different carboxyl terminus at the junction creating a novel receptor motif with a single membrane spanning domain, assigning it to the growth factor type I receptor family. In transfected cells the expressed receptor localizes on the cell surface and specific antibodies directed against the unique C-terminal portion (residues 242-259) of FSH-R3 demonstrate the presence of the receptor protein in solubilized ovarian and testicular membrane preparations. FSH binding to the transfected cells induced [Ca2+]i identifying coupling of the R3 receptor to calcium signaling pathways. Thus, a growth factor type I receptor for FSH may be implicated in the growth promoting actions of FSH in the ovary. This is the first documentation of alternative splicing of a G protein coupled receptor gene creating a different signaling motif for cellular signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527886     DOI: 10.1006/mcbr.1999.0139

Source DB:  PubMed          Journal:  Mol Cell Biol Res Commun        ISSN: 1522-4724


  6 in total

Review 1.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

2.  FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor.

Authors:  Y Li; S Ganta; C Cheng; R Craig; R R Ganta; L C Freeman
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

Review 3.  Multiple facets of follicle-stimulating hormone receptor function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Ana Ma Pasapera; Patricia Casas-González; James A Dias
Journal:  Endocrine       Date:  2008-02-02       Impact factor: 3.633

Review 4.  Overview of follicle stimulating hormone and its receptors in reproduction and in stem cells and cancer stem cells.

Authors:  Swati Haldar; Himanshu Agrawal; Sarama Saha; Alex R Straughn; Partha Roy; Sham S Kakar
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries?

Authors:  Deepa Bhartiya; Kalpana Sriraman; Pranesh Gunjal; Harshada Modak
Journal:  J Ovarian Res       Date:  2012-11-07       Impact factor: 4.234

6.  Follicle stimulating hormone modulates ovarian stem cells through alternately spliced receptor variant FSH-R3.

Authors:  Hiren Patel; Deepa Bhartiya; Seema Parte; Pranesh Gunjal; Snehal Yedurkar; Mithun Bhatt
Journal:  J Ovarian Res       Date:  2013-07-20       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.